# A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus

> **NCT07335588** · PHASE3 · NOT_YET_RECRUITING · sponsor: **LEO Pharma** · enrollment: 652 (estimated)

## Conditions studied

- Lichen Sclerosus

## Interventions

- **DRUG:** Delgocitinib
- **DRUG:** Cream Vehicle

## Key facts

- **NCT ID:** NCT07335588
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-06
- **Primary completion:** 2028-03-10
- **Final completion:** 2028-12-29
- **Target enrollment:** 652 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07335588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07335588, "A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07335588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*